We believe that the emergence of Medicine 3.0 – predicative, preventative, personalized, and participatory healthcare – presents an untapped opportunity to build companies focused on effectively delivering customized health outcomes in new and innovative ways. These companies will combine new technologies and scientific insight to significantly improve patient-consumer engagement, building the foundation of a new, proactive paradigm for health: whenever possible, prevent disease rather than wait to cure it.
| Website | http://www.cornucopiancapital.com |
| Employees | 12 (6 on RocketReach) |
| Founded | 2020 |
| Industry | Investment Management |
| Keywords | Healthcare, Personalized Medicine, Health Tech, Predictive Healthcare, Biotechnology, Medical Technology, Preventive Care, Health Outcomes, Health Innovation, Digital Health, Therapeutics, Health Services, Pharmaceutical, Biopharma, Medical Devices, Life Sciences, Clinical Trials, Drug Discovery, Wellness, Investment |
| Competitors | Morgan Stanley, Fidelity Investments, State Street Global Advisors, BlackRock, Vanguard, T. Rowe Price, Raymond James, J.P. Morgan, Invesco Ltd., Schwab Advisor Services +42 more (view full list) |
Looking for a particular Cornucopian Capital employee's phone or email?
Cornucopian Capital Questions
Aryeh Ganz is the Founder and Managing Partner of Cornucopian Capital.
6 people are employed at Cornucopian Capital.
Cornucopian Capital is based in Montclair, New Jersey.
Top Cornucopian Capital Employees
-
Aryeh Ganz
Founder and Managing Partner at Cornucopian Capital
New York, NY, US52 -
Mark McLaughlin
CEO, Co-founder at Cornucopian Capital
California, United States55+ -
Rachelle Peluso
Operating Partner at Cornucopian Capital
Montclair, NJ, US55+ -
Sibel Kaya
Operations Associate at Cornucopian Capital
Lincoln Park, NJ, US22
Related Companies
